Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
The company has been a Zacks #1 Rank (Strong Buy) since June 7, 2012.
Strong First Quarter
On April 18, 2012, LaSalle reported growth in first quarter 2012 adjusted FFO/share of 61.5% to 21 cents, exceeding the Zacks Consensus Estimate by 4 cents.
Adjusted EBITDA surged by 36.9% on a year-over-year basis to $34.0 million in the first quarter 2012, while RevPAR (revenue per available room) increased 6.2% to $127.06 driven by a 3.9% rise in the average daily rate to $176.78 and a 2.3% rise in occupancy to 71.9%.
With strong quarterly results and accretive acquisitions, LaSalle increased its dividend for the second quarter 2012 by a phenomenal 82% to 20 cents per share, or 80 cents on an annualized basis.
Fiscal Outlook Raised
LaSalle raised its fiscal 2012 adjusted FFO guidance to between $2.09 and $2.21 per share from the earlier range of $1.92 $2.05.. Hotel EBITDA margins are presently expected in the range of 32% - 33% compared to earlier projections of 31.5% - 32.8%. However RevPAR growth projections for fiscal 2012 are maintained in the range of 5.0%- 7.0%.
Surge in Earnings Estimate Revisions
Over the past 60 days, the Zacks Consensus Estimate for fiscal 2012 increased 4.8% to $2.19, while the outlook for 2013 advanced 5.9% to $2.52. The 2012 earnings estimate, at an implied growth rate of 39.5%, is at the higher end of the company guidance and should be an attractive investment proposition for aggressive growth investors.
Reasonable Valuation
LaSalles valuation looks reasonable on a price-to-earnings (P/E) and price-to-book (P/B) basis. Shares of LaSalle are currently trading at a forward P/E of 12.76x versus 11.71x for the peer group. On a P/B basis, LaSalle is currently trading at 1.34x versus 1.20x for the peer group. However, shares look pretty impressive with a ROE of 2.8%, which is better than the peer group average.
Chart Resonates Growth Potential
Since December 21, 2011, LaSalle shares have consistently fared relatively better than the simple moving average for 200 days or SMA (200). The stock has also more or less mirrored the S&P performance, beating it more often than not since year-end 2011. The year-to-date return for the stock is noteworthy at 15.44% compared to a S&P tally of 6.78%.
LaSalle Hotel Properties owns luxury and upper-upscale hotels in high barriers-to-entry markets throughout the U.S. The company specifically focuses on owning, redeveloping and repositioning upscale full-service hotels in urban, resort and convention markets. LaSalle currently owns 10,200 guest rooms in 13 markets in 9 states in the U.S. and the District of Columbia. The company presently has a market cap of $2.39 billion.
Read the full reports :
Snapshot Report on LHO